PMC:7074432 / 10108-10363 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"341","span":{"begin":10,"end":18},"obj":"Species"},{"id":"342","span":{"begin":27,"end":35},"obj":"Species"},{"id":"343","span":{"begin":175,"end":183},"obj":"Species"},{"id":"365","span":{"begin":45,"end":56},"obj":"Chemical"},{"id":"366","span":{"begin":98,"end":109},"obj":"Chemical"},{"id":"367","span":{"begin":117,"end":129},"obj":"Chemical"},{"id":"368","span":{"begin":141,"end":153},"obj":"Chemical"}],"attributes":[{"id":"A341","pred":"tao:has_database_id","subj":"341","obj":"Tax:9606"},{"id":"A342","pred":"tao:has_database_id","subj":"342","obj":"Tax:9606"},{"id":"A343","pred":"tao:has_database_id","subj":"343","obj":"Tax:9606"},{"id":"A365","pred":"tao:has_database_id","subj":"365","obj":"MESH:D053139"},{"id":"A366","pred":"tao:has_database_id","subj":"366","obj":"MESH:D002443"},{"id":"A367","pred":"tao:has_database_id","subj":"367","obj":"MESH:D000077266"},{"id":"A368","pred":"tao:has_database_id","subj":"368","obj":"MESH:D017963"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"[30] 138 patients 90% of patients received oseltamivir. The most commonly used antibiotics were ceftriaxone (25%), moxifloxacin (64%), and azithromycin (18%). Around 45% of patients received additional glucocorticoid therapy Still admitted=61.6% (n=85)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T44","span":{"begin":155,"end":157},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T45","span":{"begin":168,"end":170},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"}],"text":"[30] 138 patients 90% of patients received oseltamivir. The most commonly used antibiotics were ceftriaxone (25%), moxifloxacin (64%), and azithromycin (18%). Around 45% of patients received additional glucocorticoid therapy Still admitted=61.6% (n=85)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T97","span":{"begin":45,"end":56},"obj":"Chemical"},{"id":"T98","span":{"begin":81,"end":92},"obj":"Chemical"},{"id":"T99","span":{"begin":98,"end":109},"obj":"Chemical"},{"id":"T100","span":{"begin":117,"end":129},"obj":"Chemical"},{"id":"T101","span":{"begin":141,"end":153},"obj":"Chemical"},{"id":"T102","span":{"begin":204,"end":218},"obj":"Chemical"}],"attributes":[{"id":"A97","pred":"chebi_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A98","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"},{"id":"A99","pred":"chebi_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/CHEBI_29007"},{"id":"A100","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_63611"},{"id":"A101","pred":"chebi_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A102","pred":"chebi_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/CHEBI_24261"}],"text":"[30] 138 patients 90% of patients received oseltamivir. The most commonly used antibiotics were ceftriaxone (25%), moxifloxacin (64%), and azithromycin (18%). Around 45% of patients received additional glucocorticoid therapy Still admitted=61.6% (n=85)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T67","span":{"begin":0,"end":57},"obj":"Sentence"},{"id":"T68","span":{"begin":58,"end":160},"obj":"Sentence"},{"id":"T69","span":{"begin":161,"end":255},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"[30] 138 patients 90% of patients received oseltamivir. The most commonly used antibiotics were ceftriaxone (25%), moxifloxacin (64%), and azithromycin (18%). Around 45% of patients received additional glucocorticoid therapy Still admitted=61.6% (n=85)"}